Explain this page
Arphra AIPlain-English read on Corcept Therapeutics Incorporated’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for CORT.
Price change · trailing returns
Live · FMP| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.62% | +7.40% | +35.14% | +94.65% | -12.90% | +99.68% | -3.06% | +202.53% | +222.61% | +1054.32% | +468.19% |
Aftermarket
Live · FMPLast trade
$69.01
1 sh
Bid
$68.02
40 sh
Ask
$70.00
70 sh
Spread
$1.980
Sector & industry today
Live · FMPSectors
- Technology+0.21%
- Basic Materials+0.15%
- Financial Services-0.43%
- Industrials-0.48%
- Energy-0.58%
- Consumer Defensive-0.79%
- Consumer Cyclical-0.85%
- Real Estate-0.98%
- Healthcare-1.37%
- Communication Services-1.47%
- Utilities-2.07%
Top industries (issuer's industry highlighted)
- Biotechnology+0.06%
- Software - Infrastructure+6.80%
- Coal-6.27%
- Information Technology Services+6.00%
- Medical - Healthcare Information Services+5.23%
- Other Precious Metals+3.84%
- Broadcasting-3.48%
- Silver+2.89%
- Renewable Utilities-2.75%
- Software - Application+2.71%
- Travel Lodging-2.70%
- Internet Content & Information-2.61%
Fair value
Football field →Weighted blend
$17.07
-75.43% vs spot
Recommendation
Sell
4 of 4 methods
Method spread
0bull4bear
±5% threshold
Analyst PT consensus: $79.67 (+14.65%)
Total assets
$836.65M
Total debt
$6.11M
Cash & equiv
$120.5M
Operating CF
$142M
Free cash flow
$141.79M
Buybacks
-$245.86M
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $164.9M | -$31.2M | $-0.30 |
| Q4 Dec 2025 | $202.13M | $24.29M | $0.20 |
| Q3 Sep 2025 | $207.64M | $19.67M | $0.16 |
| Q2 Jun 2025 | $194.43M | $35.15M | $0.29 |
| Q1 Mar 2025 | $157.21M | $20.55M | $0.17 |
| Q4 Dec 2024 | $181.89M | $30.39M | $0.26 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $761.41M | $44.8M | $99.65M | $0.82 | +13.09% |
| FY 2024 | $675.04M | $136.95M | $139.73M | $1.23 | +20.70% |
| FY 2023 | $482.38M | $107.28M | $106.14M | $0.94 | +22.00% |
| FY 2022 | $401.86M | $112.63M | $101.42M | $0.87 | +25.24% |
| FY 2021 | $365.98M | $124.48M | $112.51M | $0.89 | +30.74% |